logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investor Relations
    • Overview
    • News / Events
    • Shareholder Calls/Updates
    • Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact
    • Social Media Community Guidelines

Media

    • 25 JUN 2019

    Interview with PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, at the GMP Facility

    Interview with Austrianova’s Walter H. Gunzburg at the GMP Facility

    GMP Manufacturing Facility Walkthrough

    • Posted in
    • Media
    • 22 JAN 2019

    CEO Interview: The Big Biz Show

    • Posted in
    • Media
    • 30 May 2018

    PharmaCyte Biotech Interview with Chief Executive Officer and Chief Scientific Officer – May 30, 2018

    Click to listen →

    • Posted in
    • Media
    • 06 JUL 2017

    2017 Presentation to Oncologists and Interviews from ASCO Meeting Event in Chicago

    Presentation Video:

    Dr. Lohr Interview:

    Dr. Crabtree Interview:

    • Posted in
    • Media
    • 21 JUN 2017

    2017 BIO International Conference Buzz of BIO “Pipelines of Promise” Award Winner Presentation

    • Posted in
    • Media
    • 05 SEP 2016

    CEO/CFO Magazine Interview with PharmaCyte CEO & COO

    • Posted in
    • Media
    • 02 AUG 2016

    Medical Cannabis for Cancer By Mark L. Rabe, MD

    • Posted in
    • Media
    • 23 JUNE 2016

    2016 Medical and Scientific Presentations to Clinical Oncologists in Chicago

    As PharmaCyte Biotech heads into the final preparations for its Phase 2b clinical trial in advanced pancreatic cancer, the company hosted a medical and scientific discussion of our therapy for advanced pancreatic cancer among top oncologist investigators who have expressed interest in PharmaCyte’s technology and participation in the Phase 2b clinical trial. Below you will find the 5 presentations that were delivered to those invited oncologists. After Dr. Manuel Hidalgo, a member of PharmaCyte’s medical and scientific advisory board, completed his presentation of the design of the upcoming Phase 2b clinical trial, an hour-long discussion took place between those invited oncologists and those representing PharmaCyte Biotech; Dr. Matthias Löhr, Dr. Manuel Hidalgo, Prof. Dr. Walter H. Günzburg, and Dr. Brian Salmons.

    • Posted in
    • Media
    • 20 JUNE 2016

    2016 Marcum MicroCap Conference Live Interview with Kenneth L. Waggoner

    • Posted in
    • Media
    • 29 MAY 2016

    2016 Marcum MicroCap Conference Investor Presentation

    • Posted in
    • Media
    • 01 MAR 2015

    The Evolution of Medical Cannabis Mark L. Rabe, MD

    • Posted in
    • Media
    • 23 OCT 2015

    Interview of Chief Executive Officer Kenneth L. Waggoner, JD. and Chief Operating Officer Gerald W. Crabtree, PhD. – October 23, 2015

    • Posted in
    • Media
    • 20 MAY 2015

    eHealth Radio Interview of Dr. Gerald W. Crabtree – May 20, 2015

    Dr. Gerald Crabtree, Chief Operating Officer and Director at PharmaCyte Biotechnology, a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box joins eHealth Radio and the Diabetes and Health News Channels.Listen to interview with host Eric Michaels and guest Dr. Gerald Crabtree discuss the

    Read more →

    • Posted in
    • Media
    • 02 JUN 2014

    Interview of Chief Executive Officer Kenneth L. Waggoner JD and Chief Operating Officer Gerald W. Crabtree PhD – June 2, 2014

    Read more →

    • Posted in
    • Media

Contact Us

PharmaCyte Biotech Inc.
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92653
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS

Latest News

  • PharmaCyte Biotech Begins Physical Testing of CypCaps in Response to FDA Recommendations for its Clinical Trial Product 2020-12-14T08:45:39-0500
  • PharmaCyte Biotech Successfully Completes 9-Month Stability Study 2020-12-02T09:00:57-0500

Subscribe to Our Mailing List

* indicates required
Email Format